Mark Matylewicz

Mark Matylewicz is a seasoned professional in the pharmaceutical and medical sales industry, currently serving as a Clinical Sales Specialist at Kiniksa Pharmaceuticals since August 2022. Previous experience includes roles as a Medical Sales Specialist at Esperion from February 2020 to October 2021 and as a Medical Specialist in the Cardiometabolic Division at Regeneron Pharmaceuticals from May 2015 to February 2020. Mark also held the position of Executive Sales Specialist at UCB, focusing on Immunology from May 2013 to May 2015. Notably, Mark launched the first-ever commercial product, Benlysta, for Human Genome Sciences (now GSK), achieving formulary status in major healthcare institutions in Northeastern Pennsylvania. Additionally, experience at Bristol-Myers Squibb as an Immunology Senior Territory Business Manager involved the successful launch of Orencia for rheumatoid arthritis. Mark holds a Bachelor of Science degree in Business/Marketing from the University of Scranton.